---
figid: PMC9405218__antioxidants-11-01465-g006
pmcid: PMC9405218
image_filename: antioxidants-11-01465-g006.jpg
figure_link: /pmc/articles/PMC9405218/figure/antioxidants-11-01465-f006/
number: Figure 6
figure_title: ''
caption: 'ICS II suppressed OGD-induced intracellular and mitochondrial oxidative
  stress: (a) DHE staining. Magnification ×100; scale bar, 100 μm; (b) Mito-SOX staining.
  Magnification ×100; scale bar, 50 μm; (c) quantitative analyses of DHE fluorescence
  intensity (n = 5); (d) quantitative analyses of Mito-SOX fluorescence intensity
  (n = 5); (e) ROS level (n = 6); (f) MDA level (n = 6); (g) CAT activity (n = 6);
  (h) GSH-Px activity (n = 6); (i) SOD activity (n = 6); (j) SOD1 activity (n = 6);
  (k) SOD2 activity (n = 6); (l) SOD3 activity (n = 6). The data are presented as
  the mean ± SEM. ##p < 0.01 vs. control; * p < 0.05, ** p < 0.01 vs. OGD.'
article_title: Icariside II, a Naturally Occurring SIRT3 Agonist, Protects against
  Myocardial Infarction through the AMPK/PGC-1α/Apoptosis Signaling Pathway.
citation: Yeli Li, et al. Antioxidants (Basel). 2022 Aug;11(8):1465.
year: '2022'

doi: 10.3390/antiox11081465
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI

keywords:
- Icariside II
- myocardial infarction
- oxidative stress
- SIRT3
- AMPK/PGC-1α/apoptosis pathway

---
